Clinical Trial Endpoint Adjudication Roles

By Ethical 20 Oct, 2020

Clinical Trial Endpoint Adjudication: Roles and Responsibilities

Clinical trial endpoint adjudication has emerged with the increasing use of software tools in clinical research. The ease of exchange of data and documents has allowed experts to review complex endpoints in real time while remaining blinded to any personal or treatment identifiers. However, software is not the end of the story. Clinical research professionals are manning the adjudication systems and specific SOPs govern the whole process. Here are the main roles and their respective responsibilities.

The expert clinicians (Reviewers): while being at the cutting edge of their respective medical field, experts must be trained in the use of new software and familiarize themselves with the clinical trial endpoint adjudication process. They need to take up new habits of collaboration and resolution of disagreements as well as issuing queries and managing responses.

The investigational sites must understand the purpose and process of adjudication and integrate information exchange in the study management of their patients. In addition to the regular EDC process, sites must respond to a new set of queries, arrange for document redaction and translation.

The adjudication coordinator is the “orchestra conductor” of the adjudication process. The coordinator must have a deep knowledge of the protocol and adjudication charter as well as be familiar with the software tools used. He or she must coordinate all actions, ensure all rules are followed, timelines respected and take appropriate action to keep the process flowing seamlessly. 

Finally, the software provider: must ensure continuous availability of the tools, technical support to users and regular update of the technology. The provider must be associated in the setup from the very early stages, understand all the constraints and be able to accommodate the study needs. To this end, a flexible and user-friendly platform is paramount.

Clinical trial endpoint adjudication is a young science and will most certainly evolve in the years to come. Clinical endpoint adjudication will most likely keep growing as a method of enhanced quality and precision in clinical trials. As an industry, we should stay tuned and exchange experience to improve together.

The Complete Manual / Reference Book (34 pages) with all the topics related to the Independent Endpoint Adjudication Committees Management

Clinical Event Committee - CEC, How to Manage Endpoint Adjudication Committees



Download Ethical eAdjudication for Endpoint Adjudication Dossier

Solution Description


Request a Demo of the eAdjudication® Software Solution

We are EU-GDPR compliant: Your Data will never be used improperly

Event Adjudication Charter Guide

Event Adjudication
Charter Guidebook
Free Download

Previous Next

Complementary information in clinical trial endpoints adjudication: real-world feedback working as a quality enhancer

Regardless of the quality and completeness of the clinical trial endpoints adjudication charter, feedback from the field always reveals some necessary adjustments...

Complementary Information in Clinical AdjudicationREAD MORE

A SUSAR in a COVID-19 vaccine development study: a grain of sand in the gears and a case for adjudication

The announcement in the news was chilling: A SUSAR was reported in the leading Phase III trial for the development of a vaccine against SARS-COV-2. 


Re-adjudication: When, Why and How?

There are instances where re-adjudication of some clinical endpoints is necessary and the whole process must be repeated.

Re-adjudicationREAD MORE